225
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Effect of Interventional Therapy Unexplained Dizziness and Relationship Between Dizziness Handicap Inventory and Right-to-Left Shunt Grading

, ORCID Icon, ORCID Icon, , &
Pages 803-811 | Received 11 Dec 2022, Accepted 17 Feb 2023, Published online: 01 Mar 2023

References

  • Neuhauser HK, Radtke A, von Brevern M, Lezius F, Feldmann M, Lempert T. Burden of dizziness and vertigo in the community. Arch Intern Med. 2008;168(19):2118–2124. doi:10.1001/archinte.168.19.2118
  • Kaski D. Neurological update: dizziness. J Neurol. 2020;267(6):1864–1869. doi:10.1007/s00415-020-09748-w
  • Jacobson GP, Newman CW. The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg. 1990;116(4):424–427. doi:10.1001/archotol.1990.01870040046011
  • Mutlu B, Serbetcioglu B, Cohen H. Discussion of the dizziness handicap inventory. J Vestib Res. 2013;23(6):271–277. doi:10.3233/VES-130488
  • Tamber AL, Wilhelmsen KT, Strand LI. Measurement properties of the dizziness handicap inventory by cross-sectional and longitudinal designs. Health Qual Life Outcomes. 2009;7:101. doi:10.1186/1477-7525-7-101
  • Poon DM, Chow LC, Au DK, Hui Y, Leung MC. Translation of the dizziness handicap inventory into Chinese, validation of it, and evaluation of the quality of life of patients with chronic dizziness. Ann Otol Rhinol Laryngol. 2004;113(12):1006–1011. doi:10.1177/000348940411301212
  • Cao L. Characteristics and analysis of right-to-left shunt-related dizziness in patients without hypoxemia. J Int Med Res. 2019;47(7):2921–2928. doi:10.1177/0300060519850940
  • Inglessis I, Dec GW, Palacios I, Buonanno FS. The brain’s heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease. Pharmacol Ther. 2013;139(2):111–123. doi:10.1016/j.pharmthera.2013.03.007
  • Homma S, Messé SR, Rundek T, et al. Patent foramen ovale. Nat Rev Dis Primers. 2016;2:15086. doi:10.1038/nrdp.2015.86
  • Alakbarzade V, Keteepe-Arachi T, Karsan N, Ray R, Pereira AC. Patent foramen ovale. Pract Neurol. 2020;20(3):225–233. doi:10.1136/practneurol-2019-002450
  • Kutty S, Sengupta PP, Khandheria BK. Patent foramen ovale: the known and the to be known. J Am Coll Cardiol. 2012;59(19):1665–1671. doi:10.1016/j.jacc.2011.09.085
  • Cao Q, Shen Y, Hou Z, et al. The relationship between patent foramen ovale and unexplained dizziness: a prospective analysis in China. Neuropsychiatr Dis Treat. 2022;18:1495–1505. doi:10.2147/NDT.S367140
  • Wang SB, Wang XC, Ma Y, Liu KD, Xing YQ. Right-to-left shunt detection using contrast-enhanced transcranial Doppler: a comparison of provocation maneuvers between coughing and a modified Valsalva maneuver. PLoS One. 2017;12(4):e0175049. doi:10.1371/journal.pone.0175049
  • Wessler BS, Kent DM, Thaler DE, Ruthazer R, Lutz JS, Serena J. The RoPE score and right-to-left shunt severity by transcranial Doppler in the CODICIA study. Cerebrovasc Dis. 2015;40(1–2):52–58. doi:10.1159/000430998
  • Yang Y, Guo ZN, Wu J, et al. Prevalence and extent of right-to-left shunt in migraine: a survey of 217 Chinese patients. Eur J Neurol. 2012;19(10):1367–1372. doi:10.1111/j.1468-1331.2012.03793.x
  • Lee JY, Song JK, Song JM, et al. Association between anatomic features of atrial septal abnormalities obtained by omni-plane transesophageal echocardiography and stroke recurrence in cryptogenic stroke patients with patent foramen ovale. Am J Cardiol. 2010;106(1):129–134. doi:10.1016/j.amjcard.2010.02.025
  • Elzanaty AM, Patel N, Sabbagh E, Eltahawy EA. Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements. Curr Med Res Opin. 2021;37(3):377–384. doi:10.1080/03007995.2021.1876648
  • Post RE, Dickerson LM. Dizziness: a diagnostic approach. Am Fam Physician. 2010;82(4):361–8, 369. PMID: 20704166.
  • Neuhauser HK. The epidemiology of dizziness and vertigo. Handb Clin Neurol. 2016;137:67–82. doi:10.1016/B978-0-444-63437-5.00005-4
  • Bisdorff A, Von Brevern M, Lempert T, Newman-Toker DE. Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vestib Res. 2009;19(1–2):1–13. doi:10.3233/VES-2009-0343
  • Lopez C. The vestibular system: balancing more than just the body. Curr Opin Neurol. 2016;29(1):74–83. doi:10.1097/WCO.0000000000000286
  • Chang J, Hwang SY, Park SK, et al. Prevalence of dizziness and associated factors in South Korea: a cross-sectional survey from 2010 to 2012. J Epidemiol. 2018;28(4):176–184. doi:10.2188/jea.JE20160113
  • Devendra GP, Rane AA, Krasuski RA. Provoked exercise desaturation in patent foramen ovale and impact of percutaneous closure. JACC Cardiovasc Interv. 2012;5(4):416–419. doi:10.1016/j.jcin.2012.01.011
  • Mojadidi MK, Ruiz JC, Chertoff J, et al. Patent Foramen Ovale and Hypoxemia. Cardiol Rev. 2019;27(1):34–40. doi:10.1097/CRD.0000000000000205
  • Zamyslowska-Szmytke E, Politanski P, Jozefowicz-Korczynska M. Dizziness handicap inventory in clinical evaluation of dizzy patients. Int J Environ Res Public Health. 2021;18(5):2210. doi:10.3390/ijerph18052210
  • Saver JL, Carroll JD, Thaler DE, et al; RESPECT Investigators. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377(11):1022–1032. doi:10.1056/NEJMoa1610057
  • Mas JL, Derumeaux G, Guillon B, et al; CLOSE Investigators. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377(11):1011–1021. doi:10.1056/NEJMoa1705915
  • Carroll JD, Saver JL, Thaler DE, et al; RESPECT Investigators. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368(12):1092–1100. doi:10.1056/NEJMoa1301440
  • Søndergaard L, Kasner SE, Rhodes JF, et al; Gore REDUCE Clinical Study Investigators. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377(11):1033–1042. doi:10.1056/NEJMoa1707404
  • Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117(11):1397–1404. doi:10.1161/CIRCULATIONAHA.107.727271
  • Mattle HP, Evers S, Hildick-Smith D, et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur Heart J. 2016;37(26):2029–2036. doi:10.1093/eurheartj/ehw027
  • Tobis JM, Charles A, Silberstein SD, et al. Percutaneous closure of patent foramen ovale in patients with migraine: the PREMIUM trial. J Am Coll Cardiol. 2017;70(22):2766–2774. doi:10.1016/j.jacc.2017.09.1105
  • Butera G, Biondi-Zoccai GG, Carminati M, et al. Systematic review and meta-analysis of currently available clinical evidence on migraine and patent foramen ovale percutaneous closure: much ado about nothing? Catheter Cardiovasc Interv. 2010;75(4):494–504. doi:10.1002/ccd.22232
  • Shi YJ, Lv J, Han XT, Luo GG. Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2017;17(1):203. doi:10.1186/s12872-017-0644-9
  • Elbadawi A, Barssoum K, Abuzaid AS, et al. Meta-analysis of randomized trials on percutaneous patent foramen ovale closure for prevention of migraine. Acta Cardiol. 2019;74(2):124–129. doi:10.1080/00015385.2018.1475027
  • Zhang Y, Wang H, Liu L, Nguyen TN. Patent foramen ovale closure for treating migraine: a meta-analysis. J Interv Cardiol. 2022;2022:6456272. doi:10.1155/2022/6456272
  • Qi Y, Zhang Y, Luo X, et al. Efficacy of patent foramen ovale closure for treating migraine: a prospective follow-up study. J Investig Med. 2021;69(1):7–12. doi:10.1136/jim-2020-001323
  • Garg A, Thawabi M, Rout A, Sossou C, Cohen M, Kostis JB. Recurrent stroke reduction with patent foramen ovale closure versus medical therapy based on patent foramen ovale characteristics: a meta-analysis of randomized controlled trials. Cardiology. 2019;144(1–2):40–49. doi:10.1159/000500501
  • Meier B, Kalesan B, Mattle HP, et al; PC Trial Investigators. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368(12):1083–1091. doi:10.1056/NEJMoa1211716
  • Trepels T, Zeplin H, Sievert H, et al. Cardiac perforation following transcatheter PFO closure. Catheter Cardiovasc Interv. 2003;58(1):111–113. doi:10.1002/ccd.10371
  • Schwerzmann M, Salehian O. Hazards of percutaneous PFO closure. Eur J Echocardiogr. 2005;6(6):393–395. doi:10.1016/j.euje.2005.09.007
  • Abdelghani M, Nassif M, de Bruin-Bon RHACM, et al. Aortic root geometric and dynamic changes after device closure of interatrial shunts. J Am Soc Echocardiogr. 2019;32(8):1016–1026.e5. doi:10.1016/j.echo.2019.03.022